|
Skorupa, A F; Brezinski, S C; Lesh, G et al. (2001) Expression of Golli mRNA during development in primary immune lymphoid organs of the rat. J Neuroimmunol 119:64-72
|
|
Wiemelt, A P; Lehtinen, M; McMorris, F A (2001) Agonists calcitonin, corticotropin-releasing hormone, and vasoactive intestinal peptide, but not prostaglandins or beta-adrenergic agonists, elevate cyclic adenosine monophosphate levels in oligodendroglial cells. J Neurosci Res 65:165-72
|
|
Shen, S; Wiemelt, A P; McMorris, F A et al. (1999) Retinal ganglion cells lose trophic responsiveness after axotomy. Neuron 23:285-95
|
|
Hanson Jr, M G; Shen, S; Wiemelt, A P et al. (1998) Cyclic AMP elevation is sufficient to promote the survival of spinal motor neurons in vitro. J Neurosci 18:7361-71
|
|
Mewar, R; McMorris, F A (1997) Expression of insulin-like growth factor-binding protein messenger RNAs in developing rat oligodendrocytes and astrocytes. J Neurosci Res 50:721-8
|
|
Wiemelt, A P; Engleka, M J; Skorupa, A F et al. (1997) Immunochemical visualization and quantitation of cyclic AMP in single cells. J Biol Chem 272:31489-95
|
|
McMorris, F A; McKinnon, R D (1996) Regulation of oligodendrocyte development and CNS myelination by growth factors: prospects for therapy of demyelinating disease. Brain Pathol 6:313-29
|
|
Vemuri, G S; McMorris, F A (1996) Oligodendrocytes and their precursors require phosphatidylinositol 3-kinase signaling for survival. Development 122:2529-37
|
|
Shinar, Y; McMorris, F A (1995) Developing oligodendroglia express mRNA for insulin-like growth factor-I, a regulator of oligodendrocyte development. J Neurosci Res 42:516-27
|
